Skip to main content

History of Metabolic/Bariatric Surgery and Evolution of Evidence

  • Chapter
  • First Online:
  • 559 Accesses

Abstract

Metabolic surgery dates back to the late nineteenth century. First funded in 1975, the NIH-sponsored Program on the Surgical Control of the Hyperlipidemias (POSCH) was the first randomized controlled trial (RCT) to use a metabolic surgery procedure as the intervention modality; it was also the first trial definitively to demonstrate the cardiovascular and life expectancy benefits of marked lipid reduction. In 1978, we defined metabolic surgery, “as the operative manipulation of a normal organ or organ system to achieve a biological result for a potential health gain.”

This chapter outlines the history of metabolic bariatric surgery; its known mechanisms of action; the progression of the mainstay bariatric procedures of jejunoileal bypass, Roux-en-Y gastric bypass, vertical banded gastroplasty, biliopancreatic diversion, duodenal switch, and sleeve gastrectomy; and an overview of emerging and experimental operations. The evolution of evidence for weight loss efficacy, safety, and comorbidities resolution, in particular, that of type 2 diabetes, in outcomes data from meta-analyses, RCTs, and longitudinal studies, is reviewed.

In addition to striving for technical excellence, maximum benefits, and minimal complications, it is the obligation of the metabolic surgeon to obtain knowledge of the neurohormonal interactions our procedures elicit and, perhaps thereby, determine the basic etiology of the metabolic diseases we are treating so successfully.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Boyd S. On oophorectomy in the treatment of cancer. Br Med J. 1897;2:890–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Buchwald H. Lowering of cholesterol absorption and blood levels by ileal exclusion: experimental basis and preliminary report. Circulation. 1964;29(5):713–20.

    Article  CAS  PubMed  Google Scholar 

  3. Buchwald H, Varco RL, Matts JP, for the POSCH Group, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990;323(14):946–55.

    Article  CAS  PubMed  Google Scholar 

  4. Buchwald H, Campos C, Varco RL, for the POSCH Group, et al. Effective modification by partial ileal bypass reduced long-term coronary heart disease, mortality, and morbidity: five-year post-trial follow-up: report from the POSCH. Arch Intern Med. 1998;158(11):1253–61.

    Article  CAS  PubMed  Google Scholar 

  5. Buchwald H, Matts JP, Fitch LL, for the POSCH Group, et al. Changes in sequential coronary arteriograms and subsequent coronary events. J Am Med Assoc. 1992;268(11):1429–33.

    Article  CAS  Google Scholar 

  6. Buchwald H, Rudser KD, Williams SE, Michalek V, Vagasky J, Connett JE. Overall mortality, incremental life expectancy, and cause of death at 25 years in the Program on the Surgical Control of the Hyperlipidemias (POSCH). Ann Surg. 2010;251(6):1034–40.

    Article  PubMed  Google Scholar 

  7. Buchwald H. Varco RL. Metabolic Surgery. New York: Grune & Stratton; 1978.

    Google Scholar 

  8. American Medical Association Resolution 420 (A13): Recognition of obesity as a disease, 05/16/2013. http://www.npr.org/documents/2013/jun/ama-resolution-obesity.pdf.

  9. Berthoud HR. The vagus nerve, food intake, and obesity. Reg Peptides. 2008;149(1):15–25.

    Article  CAS  Google Scholar 

  10. Zheng J, DiLOrenzo DJ, McLaughlin L, Roberts AT, Greenway FL. Stimulation of sympathetic innervation in the upper gastrointestinal tract as a treatment for obesity. Med Hypotheses. 2009;72(6):706–10.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Epstein PA. Gastroparesis. Review. Aliment Pharmacol Ther. 2008;27(9):724–40.

    Article  CAS  PubMed  Google Scholar 

  12. Bornstein JC, Furness JB. Correlated electrophysiological and histochemical studies of submucous neurons and their contribution to understanding enteric neural circuits. J Auton Nerv Syst. 1988;25:1–13.

    Article  CAS  PubMed  Google Scholar 

  13. Buchwald H, Menchaca HJ, Michalek VN, Bertin NT. Ileal effect on blood glucose, HbA1c, and GLP-1 in Goto-Kakizaki rats. Obes Surg. 2014;24(11):1954–60.

    Article  PubMed  Google Scholar 

  14. Batterham RL, Fytche DH, Rosenthal JM, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature. 2007;450(7166):106–9.

    Article  CAS  PubMed  Google Scholar 

  15. Lauritsen KB, Christensen KC, Stokholm KH. Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass. Scand J Gastroenterol. 1980;15(4):489–95.

    Article  CAS  PubMed  Google Scholar 

  16. Le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab. 2005;90(2):1068–71.

    Article  CAS  PubMed  Google Scholar 

  17. Saad MF, Riad-Gabriel MG, Khan A, et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab. 1998;83(2):453–9.

    CAS  PubMed  Google Scholar 

  18. Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med. 2015;21(11):702–14.

    Article  CAS  PubMed  Google Scholar 

  19. Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106:2365–70.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Buchwald H, Rucker RD. The rise and fall of jejunoileal bypass. In: Nelson RL, Nyhus LM, editors. Surgery of the small intestine. Norwalk: Appleton Century Crofts; 1987. p. 529–41.

    Google Scholar 

  22. Henrikson V. Kan tunnfarmsresektion forsvaras som terapi mot fettsot? Nord Med. 1952;47:744. Translations: Can small resection be defended as therapy for obesity? Obes Surg 1994; 4:54

    Google Scholar 

  23. Kremen AJ, Linner LH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140:439–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lewis LA, Turnbull RB, Page LH. “Short-circuiting” of the small intestine. JAMA. 1962;182:77–9.

    Article  CAS  PubMed  Google Scholar 

  25. Payne JH, DeWind LT, Commons RR. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 1963;106:272–89.

    Article  Google Scholar 

  26. Payne JH, DeWind LT. Surgical treatment of obesity. Am J Surg. 1969;118:141–7.

    Article  CAS  PubMed  Google Scholar 

  27. Lewis LA, Turnbull RB, Page LH. Effects of jejunocolic shunt on obesity, serum lipoproteins, lipids, and electrolytes. Arch Intern Med. 1966;117:4–16.

    Article  CAS  PubMed  Google Scholar 

  28. Sherman CD, May AG, Nye W. Clinical and metabolic studies following bowel bypassing for obesity. Ann N Y Acad Sci. 1965;131:614–22.

    Article  PubMed  Google Scholar 

  29. Scott HW, Sandstead HH, Brill AB. Experience with a new technic of intestinal bypass in the treatment of morbid obesity. Ann Surg. 1971;174:560–72.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Salmon PA. The results of small intestine bypass operations for the treatment of obesity. Surg Gynecol Obstet. 1971;132:965–79.

    CAS  PubMed  Google Scholar 

  31. Buchwald H, Varco RL. A bypass operation for obese hyperlipidemic patients. Surgery. 1971;70:62–70.

    CAS  PubMed  Google Scholar 

  32. Buchwald H, Buchwald JN. Evolution of operative procedures for the management of morbid obesity 1950–2000. Obes Surg. 2002;12(5):705–17.

    Article  PubMed  Google Scholar 

  33. Mason EE, Ito C. Gastric bypass in obesity. Surg Clin N Am. 1967;47:1345–52.

    Article  CAS  PubMed  Google Scholar 

  34. Mason EE, Printen KJ. Optimizing results of gastric bypass. Ann Surg. 1975;182:405–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Alden JF. Gastric and jejuno-ileal bypass: a comparison in the treatment of morbid obesity. Arch Surg. 1977;112:799–806.

    Article  CAS  PubMed  Google Scholar 

  36. Griffen WO, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977;186:500–7.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Flickinger EG, Pories WJ, Meelheim HD, Sinar DR, Blose IL, Thomas FT. The Greenville gastric bypass. Progress report at 3 years. Ann Surg. 1984;199(5):555–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Torres JC, Oca CF, Garrison RN. Gastric bypass: Roux-en-Y gastrojejunostomy from the lesser curvature. South Med J. 1983;76:1217–21.

    Google Scholar 

  39. Linner JR, Drew RL. New modification of Roux-en-Y gastric bypass procedure. Clin Nutr. 1986;5:33–4.

    Article  Google Scholar 

  40. Torres J, Oca CF. Gastric bypass lesser curvature with distal Roux-en-Y. Bariatric Surg. 1987;5:10–5.

    Google Scholar 

  41. Brolin RE, Kenler HA, Gorman JH, et al. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg. 1992;21:387–95.

    Article  Google Scholar 

  42. Salmon PA. Gastroplasty with distal gastric bypass: a new and more successful weight loss operation for the morbidly obese. Can J Surg. 1988;31:111–3.

    CAS  PubMed  Google Scholar 

  43. Fobi MA. Why the operation I prefer is Silastic ring vertical banded gastric bypass. Obes Surg. 1991;1:423–6.

    Article  CAS  PubMed  Google Scholar 

  44. Buchwald H, Buchwald J, McGlennon T. Systematic review and meta-analysis of medium-term outcomes after banded Roux-en-Y gastric bypass. Obes Surg. 2014;24:1536–51.

    Article  CAS  PubMed  Google Scholar 

  45. Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4:353–7.

    Article  CAS  PubMed  Google Scholar 

  46. Higa KD, Boone KB, Ho T. Laparoscopic Roux-en-Y gastric bypass for morbid obesity in 850 patients: technique and follow-up. Poster at American Society of Bariatric Surgery, 1999.

    Google Scholar 

  47. Scopinaro N, Gianetta E, Civalleri D. Biliopancreatic bypass for obesity: II. Initial experiences in man. Br J Surg. 1979;66:618–20.

    Article  CAS  PubMed  Google Scholar 

  48. Mason EE. Vertical banded gastroplasty. Arch Surg. 1982;117:701–6.

    Article  CAS  PubMed  Google Scholar 

  49. Lavorato F, Doldi SB, Scaramella R. Evoluzione storica della terapia chirurgica della grande obesita. Minerva Med. 1978;69:3847–57.

    CAS  PubMed  Google Scholar 

  50. Eriksson F. Biliointestinal bypass. Int J Obes. 1981;5:437–47.

    CAS  PubMed  Google Scholar 

  51. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experience. In: Deitel M, Cowan Jr SM, editors. Update: surgery for the morbidly obese patient. Toronto: FD-Communications Inc; 2000. p. 227–58.

    Google Scholar 

  52. Marceau P, Biron S, Bourque R-A, et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg. 1993;3:29–35.

    Article  CAS  PubMed  Google Scholar 

  53. Hess DW, Hess DS. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267–82.

    Article  CAS  PubMed  Google Scholar 

  54. Printen KJ, Mason EE. Gastric surgery for relief of morbid obesity. Arch Surg. 1973;106:428–31.

    Article  CAS  PubMed  Google Scholar 

  55. Gomez CA. Gastroplasty in morbid obesity. Surg Clin North Amer. 1979;59:1113–20.

    Article  CAS  Google Scholar 

  56. Pace WG, Martin EW, Tetirick CE, et al. Gastric partitioning for morbid obesity. Ann Surg. 1979;190:392–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. LaFave JW, Alden JF. Gastric bypass in the operative revision of the failed jejuno-ileal bypass. Arch Surg. 1979;114:438–44.

    Article  CAS  PubMed  Google Scholar 

  58. Fabito DC. Gastric vertical stapling. Read before the Bariatric Surgery colloquium, Iowa City, Iowa, June 1, 1981.

    Google Scholar 

  59. Laws HL, Piatadosi S. Superior gastric reduction procedure for morbid obesity. A prospective, randomized trial. Am J Surg. 1981;193:334–6.

    CAS  Google Scholar 

  60. Eckhout GV, Willbanks OL, Moore JT. Vertical ring gastroplasty for obesity: five year experience with 1463 patients. Am J Surg. 1986;152:713–6.

    Article  CAS  PubMed  Google Scholar 

  61. Tretbar LL, Taylor TL, Sifers EC. Weight reduction: gastric plication for morbid obesity. J Kans Med Soc. 1976;77:488–90.

    CAS  PubMed  Google Scholar 

  62. Wilkinson LH. Reduction of gastric reservoir capacity. J Clin Nutr. 1980;33:515–7.

    Article  CAS  Google Scholar 

  63. Wilkinson LH, Peloso OA. Gastric (reservoir) reduction for morbid obesity. Arch Surg. 1981;116:602–5.

    Article  CAS  PubMed  Google Scholar 

  64. Kolle K. Gastric banding. OMGI 7th Congress, Stockholm, Abst No 145, 37. 1982.

    Google Scholar 

  65. Molina M, Oria HE. Gastric segmentation: a new, safe, effective, simple, readily revised and fully reversible surgical procedure for the correction of morbid obesity. 6th Bariatric Surgery Colloquium, Iowa City. 2–3 June 1983;15 (Abst).

    Google Scholar 

  66. Kuzmak LI. Silicone gastric banding: a simple and effective operation for morbid obesity. Contemp Surg. 1986;28:13–8.

    Google Scholar 

  67. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.

    Article  PubMed  Google Scholar 

  68. Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.

    Article  CAS  PubMed  Google Scholar 

  69. Gagner M, Deitel M, Kalberer TL, Erickson AL, Crosby RD. The second international consensus summit for sleeve gastrectomy, March 19–21, 2009. Surg Obes Relat Dis. 2009;5(4):476–85.

    Article  PubMed  Google Scholar 

  70. Angrisani L, Santonicola A, Iovino A, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Doležalová-Kormanová K, Buchwald JN, Skochova D, Pichlerova D, McGlennon TW, Fried M. Five-year outcomes: laparoscopic greater curvature plication for treatment of morbid obesity. Obes Surg. 2017;27(11):2818–28.

    Article  PubMed  Google Scholar 

  72. Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypass to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8.

    Article  PubMed  Google Scholar 

  73. Sanchez-Pernaute A, Herrera MA, Pérez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20(12):1720–6.

    Article  PubMed  Google Scholar 

  74. Sanchez-Pernaute A, Rubio MA, Perez Aguirre E, Barabash A, Cabrerio L, Torres A. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients. Surg Obes Relat Dis. 2013;9:731–5.

    Article  PubMed  Google Scholar 

  75. Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg. 2002;12(Suppl 1):12S–6S.

    Article  PubMed  Google Scholar 

  76. Shikora SA, Wolfe BM, Apovian CM, et al. Sustained weight loss with vagal nerve blockade but not with sham: 18-month results of the ReCharge Trial. J Obesity. 2015;2015:365604. 8 pages. https://doi.org/10.1155/2015/365604.

  77. Tognoni V, Benavoli D, Bianciardi E, et al. Laparoscopic sleeve gastrectomy versus laparoscopic banded sleeve gastrectomy: first prospective pilot randomized study. Gastroenterol Res Pract. 2016;2016:6419603.

    Google Scholar 

  78. Kumar N. Endoscopic therapy for weight loss: gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J Gastrointest Endosc. 2015;7:847–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Patel SR, Mason J, Hakim N. The duodenal-jejunal bypass sleeve (endobarrier gastrointestinal liner) for weight loss and treatment of type II diabetes. Indian J Surg. 2012;74(4):275–7.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Norén E, Forssell H. Aspiration therapy for obesity; a safe and effective treatment. BMC Obes. 2016;3:56.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Guyatt GH. Evidence-based medicine. Ann Int Med. 1991;114(2):A-16.

    Google Scholar 

  82. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268(17):2420–5.

    Article  Google Scholar 

  83. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248–54.

    Article  CAS  PubMed  Google Scholar 

  84. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    Article  CAS  PubMed  Google Scholar 

  85. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.

    Article  PubMed  Google Scholar 

  86. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32.

    Article  PubMed  Google Scholar 

  87. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Cardoso L, Rodrigues D, Gomes L, Carrilho F. Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19(9):1223–32.

    Article  PubMed  Google Scholar 

  89. Endo I, Kumamoto T, Matsuyama R. Postoperative complications and mortality: are they unavoidable? Ann Gastro. 2017;1:160–3.

    Article  Google Scholar 

  90. Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.

    Article  PubMed  Google Scholar 

  91. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22(9):936–46.

    Article  CAS  PubMed  Google Scholar 

  93. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.

    Article  PubMed  Google Scholar 

  94. Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabet Obes Metab. 2014;16(8):719–27.

    Article  CAS  Google Scholar 

  95. Sun F, Wu S, Guo S, et al. Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetes Res Clin Pract. 2015;110(1):26–37.

    Article  CAS  PubMed  Google Scholar 

  96. Guo X, Liu X, Wang M, Wei F, Zhang Y, Zhang Y. The effects of bariatric procedures versus medical therapy for obese patients with type 2 diabetes: meta-analysis of randomized controlled trials. Biomed Res Int. 2013;2013:410609. Epub 2013 Jul 21

    PubMed  PubMed Central  Google Scholar 

  97. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (Clinical Research ed.). 2013;347 (article no. f5934).

    Google Scholar 

  98. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;24(3):437–55.

    Article  CAS  PubMed  Google Scholar 

  99. Yan Y, Sha Y, Yao G, et al. Roux-en-Y gastric bypass versus medical treatment for type 2 diabetes mellitus in obese patients: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95(17):e3462.

    Article  CAS  Google Scholar 

  100. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopancreatic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2011;253(4):699–703.

    Article  PubMed  Google Scholar 

  101. Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabet Techno Ther. 2012;14(4):365–72.

    Article  CAS  Google Scholar 

  102. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250–61.

    Article  CAS  PubMed  Google Scholar 

  103. Hsu CC, Almulaifi A, Chen JC, et al. Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes. JAMA Surg. 2015;150:1117–24.

    Article  PubMed  Google Scholar 

  104. Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care. 2016;39(6):924–33.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Ikramuddin S, Korner J, Wei-Jei L, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. JAMA. 2013;309(21):2240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the crossroads randomized controlled trial. Diabetologia. 2016;59(5):945–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Chan CP, Wang BY, Cheng CY, et al. Randomized controlled trials in bariatric surgery. Obes Surg. 2013;23(1):118–30.

    Article  PubMed  Google Scholar 

  108. Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev. 2011;12(8):602–21.

    Article  CAS  PubMed  Google Scholar 

  109. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

    Article  PubMed  Google Scholar 

  110. Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.

    Article  Google Scholar 

  111. Sampalis JS, Liberman M, Auger S, Christou NV. The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg. 2004;14(7):939–47.

    Article  PubMed  Google Scholar 

  112. Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.

    PubMed  Google Scholar 

  113. Christou N, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23. discussion 423-4

    Article  PubMed  PubMed Central  Google Scholar 

  114. Favretti F, Segato G, Ashton D, et al. Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg. 2007;17(2):168–75.

    Article  PubMed  Google Scholar 

  115. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henry Buchwald .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Buchwald, H. (2019). History of Metabolic/Bariatric Surgery and Evolution of Evidence. In: Morton, J., Brethauer, S., DeMaria, E., Kahan, S., Hutter, M. (eds) Quality in Obesity Treatment. Springer, Cham. https://doi.org/10.1007/978-3-030-25173-4_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25173-4_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25172-7

  • Online ISBN: 978-3-030-25173-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics